Reframing the IND: From Tactical Requirement to Strategic Opportunity

In this Applied Clinical Trials article, Dr. Michael Murphy focuses on how a strategic approach to the pre-investigational and investigational new drug application process can be used as a business and clinical catalyst. Read the full article here.